These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7437318)

  • 21. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.
    Goldblum SE; Van Epps DE; Reed WP
    J Clin Invest; 1979 Jul; 64(1):255-64. PubMed ID: 447856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphonuclear granulocyte chemotaxis and chemotactic factor generation by concanavalin A-stimulated peripheral blood mononuclear cells in patients with psoriasis.
    Csató M; Dobozy A; Hunyadi J; Kenderessy SA; Simon N
    Arch Dermatol Res; 1981; 271(3):259-64. PubMed ID: 7305440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of chemotactic activity of human polymorphonuclears by monoclonal IgMs with and without biological activity.
    Pruzanski W; Nitzan DW; Saito S
    Am J Hematol; 1986 Sep; 23(1):31-42. PubMed ID: 3090874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of glycogen-induced guinea pig polymorphonuclear leukocytes to detect inhibitors of chemotaxis found in human serum.
    Judd RC; Rudbach JA
    Diagn Immunol; 1985; 3(1):1-6. PubMed ID: 3995877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeine, dibutyryl cyclic-AMP and heparin affect the chemotactic and phagocytotic activities of neutrophils for boar sperm in vitro.
    Li JC; Yamaguchi S; Kondo Y; Funahashi H
    Theriogenology; 2011 Apr; 75(7):1336-45. PubMed ID: 21295837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of polymorphonuclear migration into psoriatic skin using a new in vivo method.
    Guillot B; Coupe M; Alirezai M; Bureau JP; Guilhou JJ
    Arch Dermatol Res; 1989; 280(8):477-80. PubMed ID: 2645836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Zinc levels in the leukocytes and serum of patients with psoriasis during the active phase and during remission associated with the chemotactic activity of polymorphonuclear leukocytes].
    Wasik F; Baran E; Walów B; Sierawska M; Waniewska I; Kaniowska E; Podwiński P; Andrzejak R
    Przegl Dermatol; 1985; 72(3):237-42. PubMed ID: 4081068
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of psoriatic sera on the generation of oxygen intermediates by normal polymorphonuclear leucocytes.
    Miyachi Y; Niwa Y
    Arch Dermatol Res; 1983; 275(1):23-6. PubMed ID: 6847242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Migration-stimulating effect of psoriatic scales on polymorphonuclear leukocytes.
    Lidén S; Bäck O; Pettersson A
    Arch Dermatol Res; 1980; 269(1):93-8. PubMed ID: 7447494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil and monocyte chemotaxis in pustulosis palmo-plantaris and pustular psoriasis.
    Ternowitz T; Thestrup-Pedersen K
    Br J Dermatol; 1985 Nov; 113(5):507-13. PubMed ID: 4063189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibitory effect on rabbit peritoneal leukocyte and macrophage chemotaxis by sera from patients with pulmonary sarcoidosis: significance of serum chemotactic inhibitor in sarcoidosis].
    Okuyama Y
    Hokkaido Igaku Zasshi; 1982 Mar; 57(2):197-209. PubMed ID: 7118051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotaxis or migration inhibition of rabbit peritoneal polymorphonuclear leukocytes caused by chemoattractants at various concentrations.
    Sveen K
    Acta Pathol Microbiol Scand B; 1979 Oct; 87(5):285-90. PubMed ID: 525354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes.
    van de Kerkhof PC; Bauer FW; Maassen-de Grood RM
    Br J Dermatol; 1985 Sep; 113(3):251a-255a. PubMed ID: 2998429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairment of chemotaxis of polymorphonuclear leukocytes from lead acid battery workers.
    Governa M; Valentino M; Visona I; Scielso R
    Sci Total Environ; 1988 Jun; 71(3):543-6. PubMed ID: 3406721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leucocyte motility in the newborn: determination of spontaneous movement is essential in the in vitro assessment of neutrophil chemotaxis.
    Repo H; Jokipii AM; Leirisalo M; Kosunen TU
    Clin Exp Immunol; 1980 Jun; 40(3):620-6. PubMed ID: 7418269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokinetic and chemotactic factors in psoriasis scale extracts.
    Dahl MV; Lindroos WE; Nelson RD
    J Invest Dermatol; 1978 Dec; 71(6):402-6. PubMed ID: 722120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil leukocyte migration in psoriasis vulgaris.
    Breathnach SM; Carrington P; Black MM
    J Invest Dermatol; 1981 Apr; 76(4):271-4. PubMed ID: 7205028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of chemotactic factors in serum and wound fluid by dextranomer.
    Oredsson SU; Gottrup F; Beckmann A; Hohn DC
    Surgery; 1983 Sep; 94(3):453-7. PubMed ID: 6193593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective serum chemotactic capacity in rheumatoid arthritis.
    Attia WM; Ali MK; Abu-Ghazalah LM; Shams AH; Clark HW; Brown TM; Bellanti JA
    Ann Allergy; 1983 Apr; 50(4):266-70. PubMed ID: 6838025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.